Navigation Links
Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company an Option to License Certain Alzheimer's Patents and Patent Applications
Date:10/8/2008

prevent the accumulation of aggregated beta amyloid protein fragments in the brain that are thought to be the root cause of Alzheimer's disease. In healthy people, beta amyloid does not aggregate but in Alzheimer's patients it clumps first to form long fibrils, like tentacles, that eventually deposit on the surface of nerve cells as a spaghetti-like protein mass called amyloid plaques. The beta amyloid fragments are generated as a product of metabolism from the much larger Amyloid Precursor Protein which is present in most tissues in the body and implicated in numerous important physiological functions. Intellect's immunotherapy approach for Alzheimer's disease involves making an antibody molecule available to bind to the beta-amyloid toxin, thus promoting its clearance away from sites of damage the brain. This therapeutic outcome can be potentially achieved either by administering an externally generated monoclonal antibody (passive immunization) or by provoking the patient's immune system to generate such an antibody (active immunization). Both approaches have the potential to slow or arrest disease progression provided that key safety issues are addressed. Of particular importance is the need to avoid interfering with the physiological roles of the Amyloid Precursor Protein. Intellect's has incorporated proprietary safety features into its ANTISENILIN(R) monoclonal antibody and RECALL-VAXTM technology platforms for both passive and active immunization, respectively to minimize the potential for adverse side-effects by generating antibodies that bind only the toxic beta amyloid and not the Amyloid Precursor Protein. These features and supporting patent position provides the Company with a strong competitive advantage in this field.

About Alzheimer's disease

Alzheimer's disease, the most common form of dementia, is characterized by progressive loss of memory and cognition, ultimately leading to complete debilitation and death. A hallmark feature of A
'/>"/>

SOURCE Intellect Neurosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Depression can foreshadow intellectual decline in older people
2. Therap Services to Attend 2nd International Conference on Intellectual Disabilities/Mental Retardation as Gold Sponsor
3. Written Statement of Kevin J. OConnor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement
4. StemCor Systems Announces Acquisition of Intellectual Property to Enhance Bone Marrow Aspiration Platform
5. Allarae Healthcare Inc. Announces Signing of Distribution Agreement With Intellect Inc.
6. John Josef Molenda Joins Firms Intellectual Property Practice as Of Counsel
7. Occlutech Wins Confirmation of its Intellectual Property Position Versus AGA Medical Patent by AIPPI
8. CJPS Enterprises Spins Off New Company for Intellectual Property Marketing
9. TorreyPines Therapeutics Licenses Intellectual Property from Johns Hopkins Related to Novel Uses of Glutamate Receptor Antagonists for Prevention, Treatment of Stroke, Heart Attack
10. Mutant gene causes epilepsy, intellectual disability in women
11. Intellectual Property Buildup Seminar to be Held in Detroit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 23, 2015 The U.S. Pharmacopeial ... DICVP, Director of Clinical Pharmacy Services at North Carolina ... recipient of the 2015 Beal Award for Distinguished Volunteer ... has relied on the contributions of volunteer experts to ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 LunaDress, with its ... the fashion industry. Now, the business is showing its latest ... women’s dresses. , According to the company’s CEO, all the ... now offered with big discounts, up to 80% off. All ...
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort ... TripAdvisor as the number one best large hotel for families ... world for their annual Travelers’ Choice Awards. , TripAdvisor ... website is home to millions of unbiased and honest traveler ...
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in ... Player Health Alliance (PPHA). The PPHA's passion for others' ... including NFL greats, treated for obstructive sleep apnea (OSA) has ... the cause in the valley. The most recent plans for ...
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method ... lean muscle by up to 30lbs in less than 12 ... HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. , “Our ... scientific diet formula that allows the body to pack on ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2
... adults on Medicare reports drinking more alcohol than is ... , Even though alcohol problems are more prevalent ... are consuming alcohol in amounts that exceed recommended guidelines, ... Universitys Heller School for Social Policy and Management. The ...
... Year Revenue Up 47.3% and Net Income Up 63.5% ... Company Declares Cash Dividend of US$0.18 ... Mindray,Medical International Limited (NYSE: MR ), a leading ... a rapidly growing,international presence, today announced its selected unaudited ...
... infertility risks, experts say , , WEDNESDAY, March 5 ... targeted treatment than standard chemotherapy, the effective and much-touted ... women still in their reproductive years, imatinib (Gleevec) might ... future, according to a case report published as a ...
... WALNUT CREEK, Calif., March 5 Longs Drug,Stores ... income from,continuing operations for the fourth quarter ended ... or $1.00 per diluted share, including a,$1.1 million ... of seven,California stores. Income from continuing operations for ...
... MED ) announced today that it will release fourth quarter ... 2007 on,Wednesday, March 12, 2008 after the market closes. The ... results on Thursday, March 13,2008 at 11:00 a.m. ET., ... or,(201) 689-8567, or can listen via a live Internet web ...
... 2008 The American Cancer Society, the American College ... on Colorectal Cancer (a group that comprises representatives ... Association, and American Society for Gastrointestinal Endoscopy) have ... cancer screening. The guidelines add two new tests ...
Cached Medicine News:Health News:New study sheds light on excessive drinking among the elderly 2Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 2Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 3Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 4Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 5Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 6Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 7Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 8Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 9Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 10Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 11Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 12Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 13Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 14Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 15Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 16Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 17Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 18Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 19Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 20Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 21Health News:Gleevec May Disrupt Ovarian Function 2Health News:Gleevec May Disrupt Ovarian Function 3Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 2Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 3Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 4Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 5Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 6Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 7Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 8Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 9Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 10Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 11Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 12Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 13
(Date:1/23/2015)... and Markets ( http://www.researchandmarkets.com/research/vzhr6h/video ) has announced the ... Size, Share, Growth, Trends and Forecast 2014 - 2020" ... the topic of fascination since the era of the cold ... the Soviet Russia. Earlier even a small glimpse of human ...
(Date:1/23/2015)... Biotherapeutics, Inc. (NASDAQ: NWBO )("NW Bio"), a U.S. ... inoperable solid tumor cancers, announced today that CEO Linda ... Phacilitate Immunotherapy Forum in Washington D.C. ... on January 26 at 10:30 a.m. EST at the Grand ...
(Date:1/23/2015)... 2015  Pete Rose, baseball,s all-time hits leader, is the new ... Myoflex, Ducere Pharma has announced. "Pete,s a Hall ... have him on board with Myoflex," said Ducere Pharma Chief ... player who is known across all generations. The passion and ...
Breaking Medicine Technology:Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Pete Rose bets on Myoflex to relieve aches and pains 2
... 7, 2011 Henry Schein, Inc., (Nasdaq: ... and services to office-based practitioners, announced today that ... Schein, and Steven Paladino, the Company,s Executive Vice President and ... Global Healthcare Services Conference on February 8, 2011. The conference ...
... Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ... preventive vaccines against cancers and infectious diseases, announced today ... provides the powerful enabling capabilities of electroporation without contacting ... the scientific journal Human Vaccines . While current ...
Cached Medicine Technology:Henry Schein to Present at the UBS 21st Annual Global Healthcare Services Conference 2Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery 2Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery 3Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery 4Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery 5
The anti-MAG autoantibodies EIA employs the quantitative enzymatically amplified sandwich-type immunoassay technique. HIGHLY PURIFIED MAG FROM HUMAN BRAIN has been precoated onto a microtiter plate....
... new Enzyme Immuno Assay (EIA) analyzer offering ... a dedicated EVO platform for reliable EIA ... and incubation units operated by the new ... available in three sizes - 100, 150, ...
... trial for 14 years -- and works! ... employs cutting-edge, patent-pending technology to attain the ... unsurpassed accuracy. The technique traces the amount ... blood to determine gender. Here's how it ...
Custom Pediatric Nebulizer Assembly W/Tubing...
Medicine Products: